Best yet, this growth isn't just coming from new customers. The revenue retention rate among Doximity's top 20 customers was ...

Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...

Even folks who aren't into football tune into the Super Bowl for its ads, but this year there's some "big drama" around one ...

The top barrier to entry for pharma brands considering a marketing play at the Super Bowl is the price point. A 30-second ad ...

Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for ...

The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

Unlike other brands that release their ads days or weeks ahead of the Big Game, Novartis is waiting to unveil its commercial ...

A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

Online sellers of knockoff GLP-1 drugs have seized on shortages as an opportunity to advertise a more steady, lower-cost supply of the products compared to branded versions. One such company, Hims & ...

Sen. Dick Durbin (D-Ill.) and Sen. Dr. Roger Marshall (R-Kan.) sent a letter to Food and Drug Administration acting ...

The Super Bowl debut by digital healthcare company Hims & Hers is now listed on the injury report as questionable, following ...